Anemia during pregnancy occurs in 41% of women. The most common etiology is iron deficiency, but studies to determine prevalence of other causes of anemia in pregnancy are still lacking. However, anemia in pregnancy lead to adverse pregnancy outcomes and increase risk of maternal and fœtal morbidity and mortality. Specific management of anemia is so needed.
Study Type
OBSERVATIONAL
Enrollment
700
CHRU de Brest
Brest, France
RECRUITINGPrevalence of the etiologies of anemias occured during pregnancy
Anemia in pregnancy is defined as hemoglobin level (Hb) \< 11 g/dL in the first and the third trimesters, and Hb \< 10.5 g/dL in the second trimester.
Time frame: from date of inclusion until 6 weeks after delivery
Study of obstetrical complications in women with anemia
* Measure of the incidence of postpartum haemorrhage, instrumental extractions, caesareans sections, premature delivery, intra-uterine growth restriction or small for gestational age, placenta abruption, preeclampsia and low birth-weight newborn (\<3rd and \<10th percentile under neonatal morphometry curves) * Level of release, * 1-, 3- and 5-minutes Apgar score, * Arterial ans venous cord potential hydrogen (pH)
Time frame: from date of inclusion until delivery
Study of the evolution of anemia during pregnancy and postpartum
Measure of the Hb level monthly and at 6 weeks after delivery
Time frame: from date of inclusion until 6 weeks after delivery
Describe the etiological and therapeutic management of pregnancy anemias
therapeutic management : etiologic treatment (supplemental iron, vitaminic replacement, others) and symptomatic treatment (numbers and rhythm of transfusions)
Time frame: from date of inclusion until 6 weeks after delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.